Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
May prompt earlier end-of-life ICD discussions in practice; leaves open optimal education strategies for prospective trials.
An implanted cardiac defibrillator (ICD) is a unique indwelling device for the treatment of cardiac dysrhythmia and the prevention of sudden cardiac death. On February 4, 1980, the first ICD was implanted into a human subject. Thousands of Americans have been saved as a result of this device. Near the end of life, an active ICD may no longer be consistent with a patient’s needs and/or current health status. The very benefit of the device becomes the risk. Research has shown a deficit in recipient understanding of the role and function of the ICD. Likewise, there is a deficit in physician-led discussions and education of ICD deactivation in end-of-life care.
No takes yet. Share an insight, caveat, or question.
Simm et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: